Skip to content
Catalyst

PapersPMID:42899920

[Efficacy and clinical significance of choline alfoscerate in pre-dementia cognitive impairment. (A systematic review and meta-analysis of three randomized trials)].

Zhurnal nevrologii i psikhiatrii imeni S.S2026The record ↗

  1. Finding, very limited evidenceraisesMontreal Cognitive Assessment total score

What moved

1 findingHow to read these marks →
  • Increases Montreal Cognitive Assessment total score

    very limited

    “Adding choline alfoscerate to standard therapy significantly increased MoCA scores compared with control groups.”
    Study
    meta-analysis
    Population
    Patients with mild to moderate cognitive impairment of vascular, degenerative or mixed etiology; choline alfoscerate added to standard therapy versus standard therapy alone, three pooled randomized trials

Study record

Design
meta-analysis
Species
human
Population
patients with mild to moderate cognitive impairment of vascular, degenerative, or mixed etiology
Participants
not reported
Comparator
an active treatment / no treatment
Duration
not reported
Endpoints measured
2